Identification of a novel WNK1–ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib

Yutao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui Lin(Deyang Stomatological Hospital), Tianfeng Liu(Guangdong Pharmaceutical University), Nan Li(The University of Texas MD Anderson Cancer Center), Tao Wang(Pfizer (United States)), Yue Pu
Lung Cancer
December 19, 2018
10.1016/j.lungcan.2018.12.011
Cited by 30

Related Papers

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2017|1.2k
Specific Contributions of the Small GTPases Rho, Rac, and Cdc42 to Dbl Transformation
|Journal of Biological Chemistry|1999|177
Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth
|Genes & Development|2014|123
Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling
|Nature Communications|2019|103
The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease
|Annals of Translational Medicine|2020|89